Kraig Biocraft Laboratories Inc (KBLB)

[TRUISM]

So, where is our sustained domestic production???? Since April 2017???

The only materials we were made aware are the ones provided to the army!

If you take away the PR's with respect to efforts in Vietnam, I have provided a list of what else has transpired of note since then.

Proper due diligence is essential in trying to evaluate what little KBLB gives us at times....

==================

KRAIG BIOCRAFT LABORATORIES DELIVERS FIRST FIBER SAMPLE TO MEDICAL APPLICATION FIRM FOR PERFORMANCE AND SUITABILITY TESTING--August 22, 2017

The Company is dedicating its current Dragon Silk production to fulfilling its recently exercised U.S. Army contract, but in recognition of the abundant sample requests that the Company received and due to this healthcare firm’s extensive expertise in medical technology development and innovation, the Company decided to supply a small amount of fibers, to be tested for strength, elasticity, and other properties.

KRAIG BIOCRAFT LABORATORIES TO OPEN NEW BIOTECHNOLOGY RESEARCH AND PRODUCTION CENTER-October 2, 2017

This new facility offers better environmental control, roughly three times the production space, significantly reduces overhead costs, and, for the first time in the Company’s history, will allow the Company’s research and production teams to work side by side producing today’s spider silk based products, and creating tomorrow’s possibilities.

iKRAIG BIOCRAFT LABORATORIES EXPANDS TEAM WITH APPOINTMENT OF NEW MOLECULAR BIOLOGIST- December 4, 2017

In this role he will play a key part in developing the next generation of recombinant silk fibers and protein constructions as well as overseeing all aspects of our research laboratory. Over the next 60 days the Company plans to hire additional research staff to support this role as the Company rapidly ramps up development of new and stronger transgenics and polymers.

KRAIG BIOCRAFT LABORATORIES BEGINS OPERATIONS IN NEW LABORATORY- December 14, 2017

“The opening of this new Lab is a watershed moment for the Company,” said Jon Rice, COO. “Our new facility gives us the capacity to design, develop, and test new Spider Silk formulations, which give us the ability to rapidly develop new products going into 2018. We have brought on additional staff over the last 60 days, to take our ground breaking Spider Silk technology to the next level. Recent developments have reinvigorated our team, making us as excited today, as we were when we began our journey.”

KRAIG BIOCRAFT LABORATORIES EXPANDS MATERIAL PERFORMANCE TESTING PROCEDURES- January 25, 2018

With this new expanded testing, the Company has already identified variances in material properties for its transgenic silkworm lines, which fall outside of the Company’s target ranges. This variance is believed to be the result of genetic drift within the Company’s silkworm strains.

In response to this new discovery, the Company has implemented an intensive selective breeding program to leverage the results of the newly established testing procedure. The Company has also begun a cross breeding project to reinvigorate its transgenic lines with commercial silk genetics.

Combined, the expanded testing and selective breeding efforts are designed to allow the Company to more tightly control silk properties, while at the same time, creating the necessary genetic diversity within each line.

The increased throughput and capacity for material testing, enabled by the Company’s new facilities and new testing protocol, is expected to identify even more opportunities for material and process improvements over the coming quarters. The Company intends to use these discoveries to improve its operations and its products.

KRAIG BIOCRAFT LABORATORIES SUCCESSFULLY PRODUCES RECOMBINANT SPIDER SILK COCOONS FROM NEW LINE OF HYBRID SILKWORMS- April 3, 2018

the Company has successfully produced the first recombinant spider silk cocoons from the new line of hybrid transgenic silkworms recently created at its Michigan production and research facility. This new hybrid line was created by combining one of the Company’s best performing recombinant spider silk lines with a commercial strain, resulting in the largest cocoons in the Company’s history.

The first generation cocoons from this hybrid cross have exceeded the Company’s expectations with some cocoons nearly twice as large as the original spider silk line cocoons. These larger cocoons reduce operating and handling costs throughout the production process and yield longer silk threads.

KRAIG BIOCRAFT LABORATORIES DEVELOPS NEW BREAKTHROUGH SPIDER SILK DNA SYNTHESIS PROTOCOLS ACCELERATING TIME TO MARKET FOR NEW PRODUCTS-May 23, 2018

announces today that its R&D team has achieved a major breakthrough in the construction of DNA encoding for spider silk proteins.

With this new capability the Company believes that it should be able to reduce the customization timeframe, for new spider silk technologies, by several months.

The new protocols were developed after Kraig Labs reached out to leading DNA synthesis facilities, which all stated that construction of the desired sequences would be practically impossible, due to the unique structure of spider silk proteins. Refusing to accept that answer, Kraig’s research team then took on the task directly.

Using a combination of distinct approaches, Kraig Labs successfully synthesized the highly complex set of spider silk protein construct designs. This new approach should accelerate the pace of its research and production rollout efforts, as well as reduce costs to develop new transgenics for new potential markets and applications.

The newly designed protein constructs are currently being prepared for incorporation into the Company’s spider silk platform technology. Due to their construction, these new designs may have the potential to produce new silk fibers with even greater strength and flexibility than the Company’s current generation of recombinant spider silk.

KRAIG BIOCRAFT LABORATORIES DEPLOYS NEW SPIDER SILK DNA SYNTHESIS METHODOLOGY- June 12, 2018

the Company has completed more than 2,500 microinjections using the recently announced new spider silk DNA synthesis methodology. This new method allows for faster creation of larger and more complex spider silk proteins. Larger and more complex proteins are believed to produce improved silk strength, toughness, and elasticity. These improved recombinant spider silk fibers will allow the Company to target an expanded set of end market applications.

To support this expanded research and development capability, the Company added two laboratory staff for increased testing throughput. The additional lab staff members have been trained and have conducted the majority of the microinjection effort.

By implementing this new validated protocol and completing these initial microinjections, the Company is looking forward to creating new transgenics, at Kraig Labs’ U.S. R&D headquarters, with an abridged development cycle and enhanced materials performance. The transgenics created using the new protocols are expected to be transitioned into Prodigy Textiles’, the Company’s recently announced Vietnamese subsidiary, commercial production process.

KRAIG BIOCRAFT LABORATORIES ACCELERATES DEVELOPMENT OF NEW RECOMBINANT SPIDER SILK FIBERS- September 18, 2018

announces today that it has implemented two major advancements in the development of next generation recombinant spider silk fibers.

These advancements are the result of new equipment and recently employed protocols, at the Company’s R&D headquarters, based in Michigan. These new approaches build on the existing protocols, but allow the Company to increase processing efficiency significantly. The Company expects to see higher throughput as this approach should result in shorter times to generate new transgenics. What previously took an entire day to complete can now be done in a matter of minutes.

Pre-Holiday Blessings to All

TRUTH